FI108642B - Menetelmä terapeuttisesti käyttökelpoisten 4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojen sekä niiden suolojen ja estereiden valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojen sekä niiden suolojen ja estereiden valmistamiseksi Download PDF

Info

Publication number
FI108642B
FI108642B FI904395A FI904395A FI108642B FI 108642 B FI108642 B FI 108642B FI 904395 A FI904395 A FI 904395A FI 904395 A FI904395 A FI 904395A FI 108642 B FI108642 B FI 108642B
Authority
FI
Finland
Prior art keywords
formula
isopropyl
mmol
fluorophenyl
salts
Prior art date
Application number
FI904395A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI904395A0 (fi
Inventor
Gerhard Beck
Guenther Wess
Kurt Kesseler
Heiner Jendralla
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI904395A0 publication Critical patent/FI904395A0/fi
Priority to FI963396A priority Critical patent/FI963396A/fi
Application granted granted Critical
Publication of FI108642B publication Critical patent/FI108642B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/12—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the ring of aromatic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/20—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from organic compounds containing only oxygen atoms as heteroatoms
    • C07C1/24—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from organic compounds containing only oxygen atoms as heteroatoms by elimination of water
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C07C17/2632—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions involving an organo-magnesium compound, e.g. Grignard synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/02—Thiocyanates
    • C07C331/10—Thiocyanates having sulfur atoms of thiocyanate groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C07C46/02—Preparation of quinones by oxidation giving rise to quinoid structures
    • C07C46/04—Preparation of quinones by oxidation giving rise to quinoid structures of unsubstituted ring carbon atoms in six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/24—Quinones containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI904395A 1989-09-08 1990-09-06 Menetelmä terapeuttisesti käyttökelpoisten 4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojen sekä niiden suolojen ja estereiden valmistamiseksi FI108642B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI963396A FI963396A (fi) 1989-09-08 1996-08-30 Substituoidut fenoli- ja tiofenolijohdannaiset

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3929913 1989-09-08
DE3929913A DE3929913A1 (de) 1989-09-08 1989-09-08 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte

Publications (2)

Publication Number Publication Date
FI904395A0 FI904395A0 (fi) 1990-09-06
FI108642B true FI108642B (fi) 2002-02-28

Family

ID=6388931

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904395A FI108642B (fi) 1989-09-08 1990-09-06 Menetelmä terapeuttisesti käyttökelpoisten 4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojen sekä niiden suolojen ja estereiden valmistamiseksi

Country Status (19)

Country Link
US (1) US5294724A (fr)
EP (1) EP0418648B1 (fr)
JP (1) JP3053417B2 (fr)
KR (1) KR0162081B1 (fr)
AT (1) ATE116979T1 (fr)
AU (1) AU629977B2 (fr)
CA (1) CA2024849C (fr)
DE (2) DE3929913A1 (fr)
DK (1) DK0418648T3 (fr)
ES (1) ES2067609T3 (fr)
FI (1) FI108642B (fr)
GR (1) GR3015360T3 (fr)
HU (1) HU212103B (fr)
IE (1) IE66106B1 (fr)
IL (1) IL95599A (fr)
NO (1) NO175002C (fr)
NZ (1) NZ235194A (fr)
PT (1) PT95237B (fr)
ZA (1) ZA907134B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90249A (en) * 1988-05-13 1994-01-25 Hoechst Ag 4-Hydroxytetrahydropyran-2-lobes, history of appropriate dihydrocarboxylic acids and salts, processes for their preparation and pharmaceutical preparations containing them
US5248793A (en) * 1990-10-17 1993-09-28 Warner-Lambert Company Process for the synthesis of (4R-cis)-1,1-dimethylethyl 6-iodomethyl or 6-(phenyl-substituted)sulfonyloxymethyl-2,2-dimethyl-1,3-dioxane-4-acetate
US5103024A (en) * 1990-10-17 1992-04-07 Warner-Lambert Company Process for the synthesis of (4r-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
DE4312034A1 (de) * 1993-04-13 1994-10-20 Hesch Rolf Dieter Prof Dr Med Neuartige Androgene und Anabolika
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
IL113567A0 (en) * 1994-05-06 1995-08-31 Upjohn Co Compounds useful to treat retroviral infections
US5925672A (en) 1996-12-06 1999-07-20 Neurosciences Research Foundation, Inc. Methods of treating mental diseases, inflammation and pain
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
EP1464639B1 (fr) * 1997-05-14 2007-03-07 Atherogenics, Inc. Ester de l'acide succinique du probucol pour l'inhibition de l'expression de VCAM-1
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
CN1275596C (zh) 1997-05-14 2006-09-20 阿特罗吉尼克斯公司 普罗布考单酯在制备用于治疗心血管疾病和炎性疾病的药物中的应用
JP2002511878A (ja) 1997-07-01 2002-04-16 アセロジエニクス・インコーポレイテツド 抗酸化剤による過増殖状態の治療の増強
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
CA2319761A1 (fr) 1998-06-08 1999-12-16 Advanced Medicine, Inc. Inhibiteurs multiliaison de hmg-coa reductase
AU4765101A (en) * 2000-03-21 2001-10-03 Atherogenics Inc Thioketals and thioethers for inhibiting the expression of vcam-1
AU2001253401B2 (en) 2000-04-11 2006-12-07 Atherogenics, Inc Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
CA2444429A1 (fr) * 2001-04-11 2002-11-07 Atherogenics, Inc. Procedes d'accroissement des taux de cholesterol hdl du plasma et d'amelioration de la fonctionnalite hdl avec des monoesters de probucol
AU2004204824B2 (en) 2003-01-13 2010-12-23 Salutria Pharmaceuticals Llc Process of preparing esters and ethers of probucol and derivatives thereof
US20050113445A1 (en) * 2003-02-20 2005-05-26 Daniele Piomelli Methods of treating mental diseases, inflammation and pain
WO2005102323A2 (fr) 2004-04-20 2005-11-03 Atherogenics, Inc. Procede de preparation d'esters et d'ethers de probucol et de ses derives
US20060194981A1 (en) * 2005-02-26 2006-08-31 Jass Paul A Process for preparation of probucol derivatives
CA2682258A1 (fr) 2007-03-26 2008-10-02 Salutria Pharmaceuticals Llc Procedes et compositions de derives de probucol pour le traitement du diabete
US20080280985A1 (en) * 2007-03-27 2008-11-13 Scott Robert A D Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes
CN111225672B (zh) 2017-10-16 2023-09-29 清华大学 甲羟戊酸通路抑制剂及其药物组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216127B1 (fr) * 1985-08-29 1990-09-26 Hoechst Aktiengesellschaft 6-Phénoxyméthyl-4-hydroxytétrahydropyran-2-ones, procédé pour leur préparation, leur utilisation comme médicaments, compositions pharmaceutiques et intermédiaires
DE3632893A1 (de) * 1986-09-27 1988-04-07 Hoechst Ag 4-(r)-hydroxy-6(s)-arylthiomethyl-tetrahydropyran-2-one, deren entsprechende sulfoxide und sulfone, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
US4789682A (en) * 1987-03-17 1988-12-06 Merck & Co., Inc. Antihypercholesterolemic compounds
DE3722809A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag 3-desmethyl-4-fluor-mevalonsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung und zwischenprodukte
IT1217402B (it) * 1988-04-12 1990-03-22 Donegani Guido Ist Procedimento per la preparazione di difenoli monoesteri sostituiti con gruppi arilici e prodotti cosi' ottenuti
IL90249A (en) * 1988-05-13 1994-01-25 Hoechst Ag 4-Hydroxytetrahydropyran-2-lobes, history of appropriate dihydrocarboxylic acids and salts, processes for their preparation and pharmaceutical preparations containing them
DE3819999A1 (de) * 1988-06-11 1989-12-21 Hoechst Ag Neue 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one und 6-thiphenoxymethyl-4-hydroxytetrahydropyran-2 -one, sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zur herstellung dieser verbindung, ihre verwendung als arzneimittel, pharmazeutische praeparate und neue phenole sowie thiophenole
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives

Also Published As

Publication number Publication date
IE903262A1 (en) 1991-03-13
DK0418648T3 (da) 1995-06-12
HU905827D0 (en) 1991-03-28
NO175002C (no) 1994-08-17
NO903911L (no) 1991-03-11
IL95599A0 (en) 1991-06-30
EP0418648B1 (fr) 1995-01-11
NO175002B (no) 1994-05-09
KR0162081B1 (ko) 1998-12-01
CA2024849A1 (fr) 1991-03-09
JP3053417B2 (ja) 2000-06-19
DE59008238D1 (de) 1995-02-23
JPH0399075A (ja) 1991-04-24
US5294724A (en) 1994-03-15
ES2067609T3 (es) 1995-04-01
PT95237A (pt) 1991-05-22
HU212103B (en) 1996-02-28
PT95237B (pt) 1997-06-30
NO903911D0 (no) 1990-09-07
GR3015360T3 (en) 1995-06-30
ATE116979T1 (de) 1995-01-15
CA2024849C (fr) 2002-01-01
AU6227790A (en) 1991-03-14
NZ235194A (en) 1992-06-25
ZA907134B (en) 1991-06-26
EP0418648A1 (fr) 1991-03-27
IE66106B1 (en) 1995-12-13
DE3929913A1 (de) 1991-04-04
FI904395A0 (fi) 1990-09-06
KR910006263A (ko) 1991-04-29
AU629977B2 (en) 1992-10-15
IL95599A (en) 1999-07-14
HUT56085A (en) 1991-07-29

Similar Documents

Publication Publication Date Title
FI108642B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojen sekä niiden suolojen ja estereiden valmistamiseksi
CA3019890A1 (fr) Synthese bio-enzymatique de tetrahydrocannabivarine (thc-v), de cannabinol (cbn) et de cannabivarine (cbv) et leur utilisation en tant qu'agents therapeutiques
Gravestock et al. Acetylenic bond participation in biomimetic polyene cyclizations. Model studies directed toward the synthesis of 20-keto steroids. Synthesis of dl-progesterone and dl-. DELTA. 4-androstene-3, 17-dione
EP0001534A1 (fr) Nouveaux dérivés du pyrrole, leur procédé de préparation et leurs applications en thérapeutique
EP0428423A2 (fr) Nouveaux aryloxy alcoyl benzènes, leurs procédés de préparation et les compositions pharmaceutiques en renfermant
FR2521992A1 (fr) Nouveaux composes de pyridine utiles comme medicaments
EP0037327B1 (fr) Nouveaux dérivés substitués de l'acide 3-formyl 4-méthyl pentanoique, leur préparation et leur application à la préparation d'acide 3-formyl but-3-èn-1-oique substitué
Chen et al. Thia-Fries rearrangement of aryl triflinates to trifluoromethanesulfinylphenols
Seçinti et al. Synthesis of Two Natural Furan‐Cyclized Diarylheptanoids via 2‐Furaldehyde
EP0337885B1 (fr) Nouveaux dérivés triéniques de structure chroménique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
JP2001226306A (ja) ２（３）−シクロペンタデセンー１−オンの製造方法
Saito et al. DPPH (= 2, 2‐Diphenyl‐1‐picrylhydrazyl= 2, 2‐Diphenyl‐1‐(2, 4, 6‐trinitrophenyl) hydrazyl) Radical‐Scavenging Reaction of Protocatechuic Acid Esters (= 3, 4‐Dihydroxybenzoates) in Alcohols: Formation of Bis‐alcohol Adduct
EP0685473B1 (fr) Composés benzohétérocycliques, en tant qu'antioxydants
Setälä et al. Horse radish peroxidase-catalysed oxidative coupling of methyl sinapate to give diastereoisomeric spiro dimers
US5183942A (en) Ten-membered ring enediynediols and enediynediones having DNA cleaving properties
CA2209270C (fr) Procede de preparation d'anthraquinones substituees et application a la preparation de rheines
Wagner et al. Synthesis of the New 5-Phosphomethyl-6-chromanyl Acetate of Vitamin K1 (20) by a Novel Cyclization Reaction
EP0432021A1 (fr) Nouveaux intermédiaires, leur procédé de préparation et leur utilisation pour la synthèse des vitamines A et E
FR2500441A1 (fr) Nouveaux medicaments derives de la 3-hydroxy dodecahydro benz (e) inden-7-one, produits derives de la 3-hydroxy dodecahydro benz (e) inden-7-one et leur procede de preparation
LU85138A1 (fr) Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique
IE911144A1 (en) Substituted 3-thia- and 3-oxa-alkyl flavones, process for their preparation, their application and drugs based on these compounds as well as intermediates
FR2508900A1 (fr) Procede de reparation de composes dihalogenes geminaux non satures
JP2005272376A (ja) ３−オキソシクロペンタン−１−カルボン酸の環状アセタール保護体の製造方法
EP0210886A1 (fr) Alcools tertiaires halogéno biphéniles utiles en thérapeutique dans le traitement de l'athérosclérose
서필자 et al. Synthesis of 2-Methyl-3-phenylbenzofuran Derivatives Using a-Chloro-a-(methylthio) phenylacetone

Legal Events

Date Code Title Description
FG Patent granted

Owner name: HOECHST AKTIENGESELLSCHAFT